BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3978122)

  • 1. Activation of peritoneal macrophages by lysophosphatidylcholine.
    Ngwenya BZ; Yamamoto N
    Biochim Biophys Acta; 1985 Mar; 839(1):9-15. PubMed ID: 3978122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages.
    Ngwenya BZ; Yamamoto N
    Cancer Immunol Immunother; 1986; 21(3):174-82. PubMed ID: 2938735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of lysophosphatidylcholine-treated nonadherent cells to mechanism of macrophage activation.
    Ngwenya BZ; Yamamoto N
    Proc Soc Exp Biol Med; 1990 Feb; 193(2):118-24. PubMed ID: 2300592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of vitamin D3-binding protein in activation of mouse macrophages.
    Yamamoto N; Naraparaju VR
    J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
    Yamamoto N; Homma S
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8539-43. PubMed ID: 1924312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids.
    Yamamoto N; Ngwenya BZ
    Cancer Res; 1987 Apr; 47(8):2008-13. PubMed ID: 2950993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
    Yamamoto N; Homma S; Millman I
    J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic regulation of Fc-receptor mediated phagocytosis of rabbit alveolar macrophages by surfactant phospholipids.
    Morito T; Oishi K; Yamamoto M; Matsumoto K
    Tohoku J Exp Med; 2000 Jan; 190(1):15-22. PubMed ID: 10750736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of serum proteins in the inflammation-primed activation of macrophages.
    Yamamoto N; Willett NP; Lindsay DD
    Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D-binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine.
    Homma S; Yamamoto M; Yamamoto N
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():249-57. PubMed ID: 8225394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.
    Yamamoto N; St Claire DA; Homma S; Ngwenya BZ
    Cancer Res; 1988 Nov; 48(21):6044-9. PubMed ID: 3167855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
    Yamamoto N; Naraparaju VR
    Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.
    Yamamoto N; Naraparaju VR
    Immunology; 1996 Aug; 88(4):604-10. PubMed ID: 8881764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defect in beta-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse.
    Yamamoto N; Naraparaju VR
    Immunol Lett; 1996 Apr; 50(1-2):35-40. PubMed ID: 8793557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of macrophages by ether analogues of lysophospholipids.
    Yamamoto N; Ngwenya BZ; Sery TW; Pieringer RA
    Cancer Immunol Immunother; 1987; 25(3):185-92. PubMed ID: 2824051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
    Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
    J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane.
    Griffin FM; Griffin JA; Leider JE; Silverstein SC
    J Exp Med; 1975 Nov; 142(5):1263-82. PubMed ID: 1194852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mouse macrophages by in vivo and in vitro treatment with a cyanine dye, lumin.
    Yamamoto N; Homma S; Nakagawa Y; Hayami M; Imanaga H; Kurimoto M; Mitsuhashi M; Kimoto T
    J Photochem Photobiol B; 1992 May; 13(3-4):295-306. PubMed ID: 1506993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells.
    Hara S; Shike T; Takasu N; Mizui T
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1258-66. PubMed ID: 9261255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic immunopotentiation: in vitro activation of macrophages by treatment of mouse peritoneal cells with haematoporphyrin derivative and light.
    Yamamoto N; Homma S; Sery TW; Donoso LA; Hoober JK
    Eur J Cancer; 1991; 27(4):467-71. PubMed ID: 1827722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.